Why the drug development pipeline is not delivering better medicines

Naci, Huseyin ORCID: 0000-0002-7192-5751, Carter, Alexander W. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2015) Why the drug development pipeline is not delivering better medicines. BMJ, 351. ISSN 1756-1833

Preview

PDF - Accepted Version Download (589kB) | Preview

• Author

Abstract

Despite the large number of new medicines entering the market every year, the vast majority offer few clinical advantages for patients over existing alternatives. Governments and pharmaceutical companies share the responsibility for this innovation deficit in the sector.

Item Type:	Article
Official URL:	http://www.bmj.com/thebmj
Additional Information:	© 2015 British Medical Journal Publishing Group
Divisions:	LSE Health
Subjects:	R Medicine > RS Pharmacy and materia medica
Date Deposited:	29 Oct 2015 11:56
Last Modified:	14 Nov 2024 08:15
URI:	http://eprints.lse.ac.uk/id/eprint/64220

Actions (login required)

View Item